Xuanzhu Bio-B (02575) Soars 20% in Afternoon Trading; Company Previously Announced Preliminary Discussions on a Potential Acquisition

Stock News

Sep 29

Xuanzhu Bio-B (02575) surged 20% in afternoon trading. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million.

On the news front, Xuanzhu Bio's stock price once soared 40% on September 17. The company released a voluntary announcement after trading hours that day regarding abnormal stock price fluctuations, disclosing that it is currently in preliminary discussions with a certain party regarding a potential acquisition, and the relevant negotiations are still ongoing.

The terms and conditions of the potential acquisition have not yet been finalized, and the group has not entered into any formal agreement regarding the potential acquisition as of the date of the announcement. There is no guarantee that the potential acquisition will proceed or ultimately be completed, and the transaction may not materialize.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1168063688"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168063688\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168063688?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-29 13:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168063688","market":"nz","top_or_hot":-1,"title":"Xuanzhu Bio-B (02575) Soars 20% in Afternoon Trading; Company Previously Announced Preliminary Discussions on a Potential Acquisition","media":"Stock News","content":"<p>Xuanzhu Bio-B (02575) surged 20% in afternoon trading. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million.<br><br>On the news front, Xuanzhu Bio's stock price once soared 40% on September 17. The company released a voluntary announcement after trading hours that day regarding abnormal stock price fluctuations, disclosing that it is currently in preliminary discussions with a certain party regarding a potential acquisition, and the relevant negotiations are still ongoing.<br><br>The terms and conditions of the potential acquisition have not yet been finalized, and the group has not entered into any formal agreement regarding the potential acquisition as of the date of the announcement. There is no guarantee that the potential acquisition will proceed or ultimately be completed, and the transaction may not materialize.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xuanzhu Bio-B (02575) Soars 20% in Afternoon Trading; Company Previously Announced Preliminary Discussions on a Potential Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXuanzhu Bio-B (02575) Soars 20% in Afternoon Trading; Company Previously Announced Preliminary Discussions on a Potential Acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-29 13:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Xuanzhu Bio-B (02575) surged 20% in afternoon trading. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million.<br><br>On the news front, Xuanzhu Bio's stock price once soared 40% on September 17. The company released a voluntary announcement after trading hours that day regarding abnormal stock price fluctuations, disclosing that it is currently in preliminary discussions with a certain party regarding a potential acquisition, and the relevant negotiations are still ongoing.<br><br>The terms and conditions of the potential acquisition have not yet been finalized, and the group has not entered into any formal agreement regarding the potential acquisition as of the date of the announcement. There is no guarantee that the potential acquisition will proceed or ultimately be completed, and the transaction may not materialize.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"","article_id":"1168063688","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168063688","pubTimestamp":1790660415,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Xuanzhu Bio-B (02575) surged 20% in afternoon trading. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million.On the news front, Xuanzhu Bio's stock price once soared 40%...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","BK1191":"制药","BK4585":"ETF&股票定投概念","KCAI":"KraneShares China Alpha Index ETF","02575":"轩竹生物-B"},"translate_title":"玄竹生物-B(02575)午盘大涨20%；公司此前宣布就潜在收购进行初步讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"KCAI":1,"02575":1},"content_text":"Xuanzhu Bio-B (02575) surged 20% in afternoon trading. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million.On the news front, Xuanzhu Bio's stock price once soared 40% on September 17. The company released a voluntary announcement after trading hours that day regarding abnormal stock price fluctuations, disclosing that it is currently in preliminary discussions with a certain party regarding a potential acquisition, and the relevant negotiations are still ongoing.The terms and conditions of the potential acquisition have not yet been finalized, and the group has not entered into any formal agreement regarding the potential acquisition as of the date of the announcement. There is no guarantee that the potential acquisition will proceed or ultimately be completed, and the transaction may not materialize.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}